Related Experiment Video
Updated: May 29, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Penufluridol in the treatment of schizophrenics
1Dy. Director General of Health Services (Medical) Nirman Bhavan, New Delhi.
Abstract:
Twenty nine chronic schizophrenics maintained on trifluperazinc treatment were included in the trial trifluperazinc was discontinued till relapse occured. Standard injectable trifluperazinc was reinstituted for 10 days. This was replaced by weekly dose of 20-40 mg penfluridol orally for a period of d months. Assessment was done monthly and side effects were monitored. At the end of 6 months, 28 patients not only maintained but improved in the psychiatric status. The trial has confirmed that penfluridol is a safe and effective drug which would be suitable for maintenance therapy in schizophrenic patients.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
